Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · IEX Real-Time Price · USD
6.88
+0.13 (1.93%)
Mar 28, 2024, 2:40 PM EDT - Market open

Acelyrin Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20222021
Cash & Equivalents
267.11102.24
Short-Term Investments
47.510
Cash & Cash Equivalents
314.62102.24
Cash Growth
207.72%-
Other Current Assets
1.440.06
Total Current Assets
316.06102.3
Other Long-Term Assets
3.860
Total Long-Term Assets
3.860
Total Assets
319.92102.3
Accounts Payable
5.951.13
Other Current Liabilities
9.9510.61
Total Current Liabilities
15.911.74
Other Long-Term Liabilities
10.290
Total Long-Term Liabilities
10.290
Total Liabilities
26.1911.74
Retained Earnings
-107.08-42.31
Comprehensive Income
-0.090
Shareholders' Equity
-102.86-42.06
Net Cash / Debt
314.62102.24
Net Cash / Debt Growth
207.72%-
Net Cash Per Share
202.00148.74
Working Capital
300.1690.56
Book Value Per Share
-66.04-61.18
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).